The expression landscape and clinical significance of methyltransferase-like 17 in human cancer and hepatocellular carcinoma: a pan-cancer analysis using multiple databases by Yezhou Ding, Mingyang Feng, Wanqing Chi, Xiaoyin Wang, Baoyan An, Kehui Liu, Shike Lou, Xiaolin Wang, Hui Wang

Get full text

Difficulty in differentiating liver injury from an immune checkpoint inhibitor from chemotherapy by Shike Lou, Xiaoyin Wang, Fei Yuan, Gangde Zhao, Mingyang Feng, Yezhou Ding, Lanyi Lin, Kehui Liu, Xiaolin Wang, Wanqing Chi, Hui Wang

Get full text

Combination of inflammatory score/liver function and AFP improves the diagnostic accuracy of HBV‐related hepatocellular carcinoma by Yezhou Ding, Kehui Liu, Yumin Xu, Qingqing Zhao, Shike Lou, Xiaogang Xiang, Lei Yan, Zhujun Cao, Qing Xie, Chuanwu Zhu, Shisan Bao, Hui Wang

Get full text

The safety concerns regarding immune checkpoint inhibitors in liver cancer patients rising mainly from CHB by Shike Lou, Zhujun Cao, Wanqing Chi, Xiaoyin Wang, Mingyang Feng, Lanyi Lin, Yezhou Ding, Kehui Liu, Lihong Qu, Gangde Zhao, Shisan Bao, Hui Wang

Get full text

The 20 years transition of clinical characteristics and metabolic risk factors in primary liver cancer patients from China by Yezhou Ding, Mingyang Feng, Di Ma, Gangde Zhao, Xiaolin Wang, Baoyan An, Yumin Xu, Shike Lou, Lanyi Lin, Qing Xie, Kehui Liu, Shisan Bao, Hui Wang

Get full text